Bret Taback

4.7k total citations
90 papers, 3.3k citations indexed

About

Bret Taback is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Bret Taback has authored 90 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Cancer Research, 48 papers in Oncology and 26 papers in Molecular Biology. Recurrent topics in Bret Taback's work include Breast Cancer Treatment Studies (31 papers), Breast Lesions and Carcinomas (16 papers) and Cancer Genomics and Diagnostics (14 papers). Bret Taback is often cited by papers focused on Breast Cancer Treatment Studies (31 papers), Breast Lesions and Carcinomas (16 papers) and Cancer Genomics and Diagnostics (14 papers). Bret Taback collaborates with scholars based in United States, Canada and Australia. Bret Taback's co-authors include Dave S.�B. Hoon, Christine Kuo, Kelly K. Hunt, Judy C. Boughey, Elizabeth A. Mittendorf, Gretchen Ahrendt, Lee G. Wilke, Donald L. Morton, Linda McCall and Karla V. Ballman and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Bret Taback

87 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bret Taback United States	32	1.7k	1.5k	1.1k	1.0k	855	90	3.3k
A M Hanby United Kingdom	38	1.4k 0.8×	1.8k 1.1×	1.6k 1.5×	804 0.8×	738 0.9×	82	4.4k
Antonio Cossu Italy	34	979 0.6×	1.8k 1.2×	1.9k 1.8×	684 0.7×	382 0.4×	195	4.0k
Jian‐Yong Shao China	31	2.0k 1.2×	1.6k 1.1×	2.6k 2.4×	358 0.4×	600 0.7×	116	4.6k
Claudio Clemente Italy	25	1.6k 0.9×	1.6k 1.0×	398 0.4×	1.1k 1.1×	828 1.0×	96	3.4k
Eva Balslev Denmark	28	982 0.6×	1.2k 0.8×	797 0.7×	347 0.3×	283 0.3×	123	2.4k
Hartmut Juhl United States	26	2.0k 1.2×	1.2k 0.8×	2.1k 2.0×	545 0.5×	282 0.3×	65	3.8k
W. Michael Korn United States	32	906 0.5×	2.1k 1.4×	1.2k 1.1×	654 0.6×	535 0.6×	197	3.4k
Asma Tulbah Saudi Arabia	31	837 0.5×	1.9k 1.3×	880 0.8×	496 0.5×	330 0.4×	104	3.3k
Hideaki Bando Japan	31	799 0.5×	2.0k 1.3×	1.3k 1.2×	668 0.7×	591 0.7×	205	3.6k
Rastko Golouh Slovenia	32	1.7k 1.0×	2.0k 1.3×	1.1k 1.0×	719 0.7×	301 0.4×	79	3.8k

Countries citing papers authored by Bret Taback

Since Specialization

Citations

This map shows the geographic impact of Bret Taback's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bret Taback with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bret Taback more than expected).

Fields of papers citing papers by Bret Taback

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bret Taback. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bret Taback. The network helps show where Bret Taback may publish in the future.

Co-authorship network of co-authors of Bret Taback

This figure shows the co-authorship network connecting the top 25 collaborators of Bret Taback. A scholar is included among the top collaborators of Bret Taback based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bret Taback. Bret Taback is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rao, Roshni, et al.. (2025). Incidence of Lymph Node Involvement in Clinically Node-Negative Breast Cancer Following Neoadjuvant Chemotherapy: Rationale for Selective Omission of Sentinel Lymph Node Biopsy. Clinical Breast Cancer. 25(6). 529–533.

Iwai, Yoshiko, et al.. (2022). Shaves off the Cavity or Specimen in Lumpectomy for Breast Cancer. Journal of Surgical Research. 277. 296–302. 1 indexed citations

Milton, Denái R., William H. Sharfman, Bret Taback, et al.. (2021). An Open–Label, Randomized, Multi–Center Study Comparing the Sequence of High Dose Aldesleukin (Interleukin–2) and Ipilimumab (Yervoy) in Patients with Metastatic Melanoma. OncoImmunology. 10(1). 1984059–1984059. 5 indexed citations

Behbahani, Sara, Stefano Malerba, Bret Taback, et al.. (2020). Outcomes and predictors of survival in cutaneous melanoma of the eyelid: An analysis of the National Cancer Database. Journal of the American Academy of Dermatology. 84(6). 1753–1758. 3 indexed citations

Ha, Richard, Peter Chang, Yu Gan, et al.. (2019). Fully Automated Postlumpectomy Breast Margin Assessment Utilizing Convolutional Neural Network Based Optical Coherence Tomography Image Classification Method. Academic Radiology. 27(5). e81–e86. 31 indexed citations

Ridner, Sheila H., Mary S. Dietrich, Michael S. Cowher, et al.. (2019). A Randomized Trial Evaluating Bioimpedance Spectroscopy Versus Tape Measurement for the Prevention of Lymphedema Following Treatment for Breast Cancer: Interim Analysis. Annals of Surgical Oncology. 26(10). 3250–3259. 49 indexed citations

Ha, Richard, Peter Chang, Jenika Karcich, et al.. (2018). Predicting Post Neoadjuvant Axillary Response Using a Novel Convolutional Neural Network Algorithm. Annals of Surgical Oncology. 25(10). 3037–3043. 26 indexed citations

Ridner, Sheila H., Mary S. Dietrich, Jennifer K. Doersam, et al.. (2018). A Prospective Study of L-Dex Values in Breast Cancer Patients Pretreatment and Through 12 Months Postoperatively. Lymphatic Research and Biology. 16(5). 435–441. 42 indexed citations

Blake, Zoë, Douglas K. Marks, Robyn D. Gartrell, et al.. (2018). Complete intracranial response to talimogene laherparepvec (T-Vec), pembrolizumab and whole brain radiotherapy in a patient with melanoma brain metastases refractory to dual checkpoint-inhibition. Journal for ImmunoTherapy of Cancer. 6(1). 25–25. 29 indexed citations

10.

Clark, Joseph I., Jatinder Singh, Marc S. Ernstoff, et al.. (2018). A multi-center phase II study of high dose interleukin-2 sequenced with vemurafenib in patients with BRAF-V600 mutation positive metastatic melanoma. Journal for ImmunoTherapy of Cancer. 6(1). 76–76. 13 indexed citations

11.

Lim, Emerson A., Jacqueline Gunther, Hyun Koo Kim, et al.. (2017). Diffuse optical tomography changes correlate with residual cancer burden after neoadjuvant chemotherapy in breast cancer patients. Breast Cancer Research and Treatment. 162(3). 533–540. 13 indexed citations

12.

Ha, Richard, Christine H. Rohde, Jeffrey A. Ascherman, et al.. (2017). Expanding the Criteria for Nipple-Sparing Mastectomy in Patients With Poor Prognostic Features. Clinical Breast Cancer. 18(3). 229–233. 26 indexed citations

13.

Mema, Eralda, et al.. (2016). Cystic metastatic lymph nodes in malignant melanoma: a case report. Clinical Imaging. 42. 158–160.

14.

Boughey, Judy C., Linda McCall, Karla V. Ballman, et al.. (2014). Tumor Biology Correlates With Rates of Breast-Conserving Surgery and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer. Annals of Surgery. 260(4). 608–616. 322 indexed citations

15.

Kaufman, Howard L., Bret Taback, William H. Sherman, et al.. (2009). Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma. Journal of Translational Medicine. 7(1). 2–2. 55 indexed citations

16.

Kim‐Schulze, Seunghee, Hong Sung Kim, Dae Won Kim, et al.. (2008). Intrarectal Vaccination with Recombinant Vaccinia Virus Expressing Carcinoembronic Antigen Induces Mucosal and Systemic Immunity and Prevents Progression of Colorectal Cancer. The Journal of Immunology. 181(11). 8112–8119. 14 indexed citations

17.

Taback, Bret, Sukamal Saha, & Dave S.�B. Hoon. (2006). Comparative Analysis of Mesenteric and Peripheral Blood Circulating Tumor DNA in Colorectal Cancer Patients. Annals of the New York Academy of Sciences. 1075(1). 197–203. 26 indexed citations

18.

Taback, Bret, Armando E. Giuliano, Nora Hansen, et al.. (2006). Epigenetic Analysis of Body Fluids and Tumor Tissues. Annals of the New York Academy of Sciences. 1075(1). 211–221. 34 indexed citations

19.

Hoon, Dave S.�B., et al.. (2004). Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients. Oncogene. 23(22). 4014–4022. 195 indexed citations

20.

Duda, Rosemary B., et al.. (1996). pS2 expression induced by American ginseng in MCF-7 breast cancer cells. Annals of Surgical Oncology. 3(6). 515–520. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact